Trial intelligence / Profile preview

Preoperative tranexamic acid in enhanced recovery total joint arthroplasty

ChiCTR2000029798Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in arthritis and rheumatoid arthritis (RA) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: blood loss. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

arthritisrheumatoid arthritis (RA)

Beyond the preview

Go deeper on ChiCTR2000029798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call